Unknown

Dataset Information

0

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.

ABSTRACT: The transcriptional coactivator YAP1 controls the balance between cell proliferation and apoptosis. YAP1 overexpression is linked to poor prognosis in many cancer types, yet its role in prostate cancer is unknown. Here, we applied YAP1 immunohistochemistry to a tissue microarray containing 17,747 clinical prostate cancer specimens. Cytoplasmic and nuclear YAP1 staining was seen in 81% and 63% of tumours. For both cytoplasmic and nuclear YAP1 staining, high levels were associated with advanced tumour stage, classical and quantitative Gleason grade, positive nodal stage, positive surgical margin, high KI67 labelling index, and early biochemical recurrence (p?

SUBMITTER: Marx A 

PROVIDER: S-EPMC7265544 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The transcriptional coactivator YAP1 controls the balance between cell proliferation and apoptosis. YAP1 overexpression is linked to poor prognosis in many cancer types, yet its role in prostate cancer is unknown. Here, we applied YAP1 immunohistochemistry to a tissue microarray containing 17,747 clinical prostate cancer specimens. Cytoplasmic and nuclear YAP1 staining was seen in 81% and 63% of tumours. For both cytoplasmic and nuclear YAP1 staining, high levels were associated with advanced tu  ...[more]

Similar Datasets

Unknown The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
| S-EPMC7463744 | biostudies-literature
Unknown Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
| S-EPMC4338420 | biostudies-literature
Unknown Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers.
| S-EPMC4904900 | biostudies-other
Unknown Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.
| S-EPMC4057660 | biostudies-literature
Unknown High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
| S-EPMC5528446 | biostudies-literature
Unknown Amotl2a interacts with the Hippo effector Yap1 and the Wnt/?-catenin effector Lef1 to control tissue size in zebrafish.
| S-EPMC4596637 | biostudies-literature
Unknown Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.
| S-EPMC5333361 | biostudies-literature
Unknown Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1.
| S-EPMC3283704 | biostudies-literature
Transcriptomics Circulating microRNAs predict biochemical recurrence in prostate cancer patients
2013-05-22 | E-GEOD-47125 | biostudies-arrayexpress
Transcriptomics Circulating microRNAs predict biochemical recurrence in prostate cancer patients
2013-05-22 | GSE47125 | GEO